1 TCCAP: a Targeted Awareness Program to Address Colorectal Cancer Disparities in Northeast Pennsylvania Samuel M. Lesko, MD, MPH Regina Schmid-Allen, MHA Laura Toole, LCSW Northeast Regional Cancer Institute, Scranton, PA
2 Acknowledgement Supported by grants from: The Harry & Jeanette Weinberg Foundation, Scranton Area Foundation, Blue Ribbon Foundation, Margaret Briggs Foundation, Sordoni Foundation, Inc., Procter & Gamble Fund, Southern Union Co., Pennsylvania Department of Health, Pennsylvania Department of Community & Economic Development, and in-kind support
3 Northeast Regional Cancer Institute Non-profit, community based organization with a commitment to ease the burden of Cancer in Northeast Pennsylvania. Cancer Registry Research Education and Support Cancer Risk
4 Appalachia Community Cancer Network (ACCN): Appalachian Areas of 7 States (KY, MD, NY, OH, PA, VA, WV)
5 Background Colorectal cancer 4 th most common Ca in US 2 nd leading cause of Ca deaths in US Screening can prevent CRCa deaths Colorectal cancer in NEPA Most commonly diagnosed Ca 2 nd leading cause of Ca death
6 Cancer Cases, NEPA 1998-’02
7 CRCa SIRs, Both Sexes, 1998-’02
8 CRCa, Stage at Diagnosis, Both Sexes Percent
9 TCCAP Goals 1.To improve colorectal cancer screening rates 2.To improve the stage at which new colorectal cancer cases are diagnosed 3.To decrease colorectal cancer mortality rates
10 Methods (1) Awareness Program Multi-faceted Community Healthcare Providers 3-year ( )
11 Methods (2) Community Advisory Council Ellen Althouse, RN William Auriemma, MD Joseph Bannon, MD Michael Barrett, MD Valerie Bell, RN Maureen Besancon Derry Bird M.R. Chowdhury, MD Edward Dzielak, MD Mary Erwine, RN, MSN Pat Finan Marcie Grello, BS Linda Gutierrez, MD Mrs. Ceil Hughes Rita Ives, RN, AOCN David Kalinoski Jamie Kane Robert Kearns Susan Kennedy Doug Klamp, MD Michael Kondash, MD Lisa Kuter Bob Lamson Pat Lawless, MHA Ina Lubin Gail Matisko, RN, BSN John McGeehan, MD Sally McGuire Judge Carmen Minora Erin Moskel Peter C. Olden, PhD Stacey Ondik Dipti Pancholy, MD Bharat Patel, MD Paul Remick, MD David D. Reynolds, MD Judy Rogers, CRN David Rutta, MD Marie Santilli Karen Saunders Nayan C. Shah, MD Eileen Sharp, PhD Beth Taylor, RN, OCN Kristin Tigue Michael Turock, MD Kim Vangarelli Vera Walline, MPH, CHES Ann Ward Gloria Watson Barbara L. Winters, PhD Robert E. Wright, MD Eileen Zuber
12 Methods (3) Community Interventions Advertisements –Print, Billboards, Broadcast
13
14
15 Methods (3) Community Interventions Advertisements –Print, Billboards, Broadcast Direct Mail –Screen for Life
16
17 Methods (3) Community Interventions Advertisements –Print, Billboards, Broadcast Direct Mail –Screen for Life Printed Materials Educational Programs CASUAL Day
18 SM
19 Methods (4) Healthcare Provider Interventions Didactic Presentations –Grand Rounds –Continuing Ed. Academic Detailing –PCPs
20
21
22 Evaluation Questionnaires HCP Follow-up Calls Population Survey Cancer Registry Data
23 Results: Community (1) Community 206 total community programs - 8,017 attendees 46,510 targeted mail pieces 59,725 total pieces of educational materials 38,712,582 total individual market impressions
24 Results: Community (2) Programs 97% Reported Knowledge Gain 96% Planned to Change Behavior Direct Mail 65% Reported Knowledge Gain 86% Planned to be Screened
25 C.A.S.U.A.L. Day Team Captains – more than 400 businesses engaged Participants – more than 12,000 Money Raised – more than $124,000 raised to support Cancer Institute colon cancer awareness programming
26 Results: HCP (1) Healthcare Professionals 21 hospital-based programs attendees 9 non-hospital programs attendees 38 non-physician provider programs attendees 230 physician “detailing” sessions
27 Results: HCP (2) CME Programs 98% Reported Knowledge Gain 95% Planned to Change Behavior Detailing Sessions 44% Requested Additional Materials 75% Reported increased Patient Request for Screening 70% Reported Increased Screening
28 Prevalence of Screening Lower Endoscopy in NEPA by Year, Endoscopy < 5 yrs Percent
29 Colorectal Cancer Stage at Diagnosis in NEPA by Year, Percent
30 Results: Mortality Too Early to Tell!
31 Discussion Community Effort – Media, CASUAL Day 13 Fewer Deaths per Year –Change in Dx –Stage-specific Survival –Stable Incidence Duration of effects - Unknown Limitations – –No Control –FOBT Use
32 Implications Sustainable – Cost Modest –$4,102/Year of Life Saved Replicable
33